Molecular testing and personalized treatment of lung cancer
F Sampsonas, D Ryan, D McPhillips… - Current molecular …, 2014 - ingentaconnect.com
Lung malignancy is a leading cause of cancer related morbidity and mortality worldwide.
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …
Molecular testing and personalized treatment of lung cancer
F Sampsonas, D Ryan… - Current molecular …, 2014 - pubmed.ncbi.nlm.nih.gov
Lung malignancy is a leading cause of cancer related morbidity and mortality worldwide.
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …
Molecular testing and personalized treatment of lung cancer.
F Sampsonas, D Ryan, D McPhillips… - Current Molecular …, 2014 - europepmc.org
Lung malignancy is a leading cause of cancer related morbidity and mortality worldwide.
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …
The majority (85%) of cases are histologically proven non-small cell lung carcinomas …